Why Is Plus Therapeutics Stock (PSTV) Up 100% Today?
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
This approval covers the use of REYOBIQ as a potential treatment for pediatric patients with supratentorial recurrent, refractory, or progressive high-grade glioma (HGG) and ependymoma. The company will conduct a clinical trial of this, with the U.S. Department of Defense providing a $3 million grant to fund the study.
PSTV stock was up 103.69% in pre-market trading on Wednesday, following a 1.47% rally yesterday. However, the shares are down 83.74% year-to-date and have seen much volatility in 2025. This makes the stock a dangerous gambit not fit for risk-averse traders.
Is Plus Therapeutics Stock a Buy, Sell, or Hold?
Turning to Wall Street, the analysts' consensus rating for Plus Therapeutics is Strong Buy, based on three Buy and one Hold rating over the past three months. With that comes an average PSTV stock price target of $10, representing a potential 5,247.59% upside for the shares.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
Nvidia CEO says Chinese military unlikely to use its AI chips, Bloomberg says
Nvidia (NVDA) CEO Jensen Huang said the U.S. government does not need to be concerned about its technology being used by the Chinses military, Ian King of Bloomberg reports. Huang said the Chinese military will avoid using U.S. technology due to the risks associated with doing so. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Business Insider
2 hours ago
- Business Insider
Amazon announces Prime Day 2025 was its biggest Prime Day event
Amazon announced that 'Prime Day 2025 was its biggest Prime Day event ever and that customers saved billions on deals across more than 35 product categories, more savings than any previous Prime Day event,' the company said. This year's Prime Day event was bigger than any previous four-day period that included a Prime Day event, with record sales and more items sold during the four days. 'This year's extended Prime Day event delivered incredible savings to our members across millions of deals,' said Doug Herrington, CEO of Amazon Worldwide Stores. 'We're thrilled to see record savings for our customers, who found great prices on the everyday essentials and products they love. This event wouldn't be possible without the dedication of our employees, delivery partners, vendors, and sellers who worked tirelessly to serve our customers. Their efforts made this our biggest Prime Day yet, and I'm grateful for their contributions.' Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. See Insiders' Hot Stocks on TipRanks >>
Business Insider
3 hours ago
- Business Insider
Zions Bancorp price target raised to $57 from $54 at BofA
BofA analyst Brandon Berman raised the firm's price target on Zions Bancorp (ZION) to $57 from $54 and keeps an Underperform rating on the shares. The firm adjusted regional bank price targets as part of a Q2 earnings preview. A lack of interest rate cuts delay a rebound in growth, but 'resilient' earnings, an acceleration in loan growth, and investment banking activity server as catalysts for the stocks, the analyst tells investors in a research note. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
